PALB2 and invasive ductal breast carcinoma: The PALB2 truncating mutation c.1653T>A (p.Tyr551Stop) was identified in a woman diagnosed with an infiltrating ductal carcinoma (IDC), negative for estrogen receptor (ER), progesterone receptor (PR) and HER2 at the age of 36.